Arcturus Therapeutics Holdings Inc. (ARCT)

NASDAQ: ARCT · Real-Time Price · USD

14.34

+0.89 (6.62%)

At close: Aug 24, 2026, 4:00 PM EDT

14.61

+0.27 (1.86%)

Pre-market: Aug 25, 2026, 6:03 AM EDT

ARCT Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	29.37	82.03	152.31	166.8	206	12.36
Revenue Growth	-75.95%	-46.14%	-8.69%	-19.03%	1566.79%	29.56%
Cost of Revenue	86.78	112.21	195.16	192.13	147.75	173.76
Gross Profit	-57.42	-30.18	-42.85	-25.33	58.25	-161.4
Selling, General & Admin	44.88	46.08	52.82	52.87	46.07	41.45
Operating Expenses	44.88	46.08	52.82	52.87	46.07	41.45
Operating Income	-102.29	-76.26	-95.67	-78.21	12.18	-202.85
Interest Expense	-0.01	-0.01	-	-	-	-
Interest & Investment Income	8.52	10.1	15.2	16.59	-	-
Earnings From Equity Investments	-	-	-	-	-0.52	0.52
Currency Exchange Gain (Loss)	0.38	0.38	-0.47	-0.23	-0.6	0.58
Other Non Operating Income (Expenses)	0.13	-	-	-	-0.42	-1.92
EBT Excluding Unusual Items	-93.28	-65.78	-80.95	-61.84	10.64	-203.67
Other Unusual Items	-	-	-	33.95	-	-
Pretax Income	-93.28	-65.78	-80.95	-27.89	10.64	-203.67
Income Tax Expense	-0	-	-0	1.84	1.3	-
Net Income	-93.28	-65.78	-80.94	-29.73	9.35	-203.67
Net Income to Common	-93.28	-65.78	-80.94	-29.73	9.35	-203.67
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	28	27	27	27	26	26
Shares Outstanding (Diluted)	28	27	27	27	27	26
Shares Change	3.47%	1.43%	1.40%	-1.72%	2.95%	29.61%
EPS (Basic)	-3.33	-2.40	-3.00	-1.12	0.35	-7.74
EPS (Diluted)	-3.33	-2.40	-3.00	-1.12	0.35	-7.74
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-72.82	-74.5	-60.4	-21	24.27	-138.45
Free Cash Flow Per Share	-2.60	-2.72	-2.24	-0.79	0.90	-5.26
Gross Margin	-195.50%	-36.79%	-28.13%	-15.19%	28.28%	-
Operating Margin	-348.32%	-92.97%	-62.81%	-46.89%	5.91%	-1641.33%
Profit Margin	-317.61%	-80.19%	-53.14%	-17.82%	4.54%	-1647.98%
Free Cash Flow Margin	-247.96%	-90.82%	-39.65%	-12.59%	11.78%	-1120.23%
EBITDA	-99.55	-73.24	-92.13	-75.25	13.7	-201.66
EBITDA Margin	-	-89.28%	-60.48%	-45.11%	6.65%	-
D&A For EBITDA	2.75	3.03	3.54	2.96	1.53	1.19
EBIT	-102.29	-76.26	-95.67	-78.21	12.18	-202.85
EBIT Margin	-	-92.97%	-62.81%	-46.89%	5.91%	-
Effective Tax Rate	-	-	-	-	12.17%	-
Revenue as Reported	29.37	82.03	152.31	166.8	206	12.36

SEC Filings: 10-K · 10-Q